Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) EPS (Basic) (2016 - 2025)

Sanara MedTech's EPS (Basic) history spans 15 years, with the latest figure at -$4.44 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 708.22% year-over-year to -$4.44; the TTM value through Dec 2025 reached -$4.98, down 2065.22%, while the annual FY2025 figure was -$4.36, 1795.65% down from the prior year.
  • EPS (Basic) reached -$4.44 in Q4 2025 per SMTI's latest filing, down from $0.1 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.73 in Q4 2024 to a low of -$4.44 in Q4 2025.
  • Average EPS (Basic) over 5 years is -$0.39, with a median of -$0.22 recorded in 2023.
  • Peak YoY movement for EPS (Basic): tumbled 1100.0% in 2021, then skyrocketed 2533.33% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$0.48 in 2021, then decreased by 6.25% to -$0.51 in 2022, then soared by 94.12% to -$0.03 in 2023, then surged by 2533.33% to $0.73 in 2024, then crashed by 708.22% to -$4.44 in 2025.
  • Per Business Quant, the three most recent readings for SMTI's EPS (Basic) are -$4.44 (Q4 2025), $0.1 (Q3 2025), and -$0.23 (Q2 2025).